Aptose Biosciences Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Product Pipeline
    • Overview
    • Tuspetinib for AML
    • Luxeptinib for B-cell Tumors
    • Luxeptinib for Myeloid Tumors
    • Posters & Presentations
  • Clinical Trials
    • Overview
    • Luxeptinib for CLL & NHL
    • Luxeptinib for AML
    • Tuspetinib (HM43239) for AML
    • Expanded Access
  • News
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • SEDAR
    • Governance
  • Careers
  • Contact

Press Releases

News

News

  • Press Releases
  • Presentations
  • Events

Aptose Biosciences to Participate in Cantor’s The Future of Oncology Virtual Symposium

Mar 28, 2023 4:01pm EDT

Aptose Reports Results for the Fourth Quarter and Full Year 2022

Mar 23, 2023 4:44pm EDT

Aptose Reports Immaterial Financial Exposure to Silicon Valley Bank

Mar 10, 2023 6:44pm EST

Aptose to Report Fourth Quarter and Full Year 2022 Financial Results and Hold Conference Call on Thursday, March 23, 2023

Mar 09, 2023 4:05pm EST

Aptose Biosciences to Present at Oppenheimer 33rd Annual Healthcare Conference

Mar 02, 2023 7:30am EST

Aptose Initiates Dosing of Tuspetinib in APTIVATE Expansion Trial in Patients with Acute Myeloid Leukemia

Jan 30, 2023 7:00am EST

Aptose Biosciences to Present at Biotech Showcase™ 2023 Conference

Dec 28, 2022 7:30am EST

Aptose Biosciences Establishes New At-The-Market Facility

Dec 12, 2022 6:15am EST

Aptose Announces Updated Clinical Responses, Breadth of Activity, and Safety Across Four Dose Levels of Tuspetinib in Difficult-to-Treat Acute Myeloid Leukemia Populations

Dec 11, 2022 9:00am EST

Aptose to Hold Clinical Update and Data Review of AML Drug Tuspetinib on Sunday, December 11th

Dec 07, 2022 4:05pm EST
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...26
Next
© 2023 Aptose Biosciences Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap